Jamison Private Wealth Management, Inc. Crispr Therapeutics Ag Transaction History
Jamison Private Wealth Management, Inc.
- $602 Billion
- Q2 2024
A detailed history of Jamison Private Wealth Management, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 5,744 shares of CRSP stock, worth $318,160. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,744
Previous 5,870
2.15%
Holding current value
$318,160
Previous $400 Million
22.46%
% of portfolio
0.05%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding CRSP
# of Institutions
544Shares Held
56.3MCall Options Held
2.91MPut Options Held
2.47M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.16MShares$452 Million3.97% of portfolio
-
Capital International Investors Los Angeles, CA7.84MShares$434 Million0.11% of portfolio
-
Nikko Asset Management Americas, Inc.3.27MShares$181 Million2.23% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$175 Million0.13% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.7MShares$150 Million0.11% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.32B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....